 |
|
Effect of a Single Mass Antibiotic Distribution on the Prevalence of Infectious Trachoma
Jaya D. Chidambaram, MBBS;
Wondu Alemayehu, MD, MPH;
Muluken Melese, MD, MPH;
Takele Lakew, MD, MPH;
Elizabeth Yi, BA;
Jenafir House, MPH, MSW;
Vicky Cevallos, MT;
Zhaoxia Zhou, BS;
Kathryn Maxey, MS;
David C. Lee, BA;
Brett L. Shapiro, BA;
Muthiah Srinivasan, MBBS;
Travis Porco, PhD, MPH;
John P. Whitcher, MD, MPH;
Bruce D. Gaynor, MD;
Thomas M. Lietman, MD
JAMA. 2006;295:1142-1146.
Context The World Health Organization recommends mass antibiotic distributions in its strategy to eliminate blinding trachoma as a public health concern. Some hypothesize that a single distribution is sufficient to control the ocular strains of chlamydia that cause trachoma. Others believe infection will inevitably return and periodic treatments or other measures are essential.
Objective To determine whether ocular chlamydial infection returns to the community up to 24 months after a single mass antibiotic distribution in a hyperendemic region of Ethiopia.
Design, Setting, and Participants Longitudinal cohort study conducted March 2003 to March 2005 in the Gurage Zone of Ethiopia. Eight randomly selected villages were assessed for ocular chlamydial infection. Fifteen untreated villages were randomly chosen at 12 months to allow assessment of a secular trend.
Intervention A single dose of oral azithromycin was offered to all residents of the 8 selected villages who were aged 1 year or older.
Main Outcome Measure Prevalence of ocular chlamydial infection in all children aged 1 to 5 years from each intervention village prior to treatment and 2, 6, 12, 18, and 24 months after mass antibiotic treatment, and also in untreated villages enrolled at 12 months.
Results Five hundred fifteen children were examined for ocular chlamydial infection at baseline. For the follow-up examinations, the mean participation rate was 83%. The mean prevalence of infection in children aged 1 to 5 years decreased from 43.5% (95% confidence interval [CI], 35.0%-52.0%) to 5.1% (95% CI, 1.1%-9.2%) after treatment. On average, infection returned gradually over 24 months to 11.3% (95% CI, 4.5%-18.1%; P = .001). In 7 of 8 villages, infection was higher at 24 months than at 2 months. In the remaining village, no infection could be identified at any point after treatment. Villages enrolled at 12 months had significantly fewer infections than those enrolled 12 months earlier, suggesting a secular trend (P<.001).
Conclusions Ocular chlamydial infection was not eliminated in children aged 1 to 5 years after a single mass azithromycin distribution; it slowly returned over 24 months, although not to baseline levels. Repeated treatments or other effective measures will be necessary for elimination.
Author Affiliations: F. I. Proctor Foundation (Drs Chidambaram, Porco, Whitcher, Gaynor, and Lietman, Mss Yi, House, Cevallos, Zhou, and Maxey, and Messrs Lee and Shapiro), Departments of Ophthalmology (Drs Whitcher, Gaynor, and Lietman) and Epidemiology and Biostatistics (Drs Whitcher and Lietman), and Institute for Global Health (Drs Whitcher and Lietman), University of California, San Francisco; Orbis International, Addis Ababa, Ethiopia (Drs Alemayehu, Melese, and Lakew); Aravind Eye Hospital, Madurai, India (Dr Srinivasan); and California Department of Health Services, Berkeley (Dr Porco).
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
The impact of community level treatment and preventative interventions on trachoma prevalence in rural Ethiopia
Cumberland et al.
Int J Epidemiol 2008;37:549-558.
ABSTRACT
| FULL TEXT
Comparison of Annual and Biannual Mass Antibiotic Administration for Elimination of Infectious Trachoma
Melese et al.
JAMA 2008;299:778-784.
ABSTRACT
| FULL TEXT
Mass Antibiotic Administration for Eradication of Ocular Chlamydia trachomatis
Mabey and Solomon
JAMA 2008;299:819-821.
FULL TEXT
Relationship between Trachoma and Chronic and Acute Malnutrition in Children in Rural Ethiopia
Smith et al.
J Trop Pediatr 2007;53:308-312.
ABSTRACT
| FULL TEXT
The Return of Trachoma in Partially Treated Communities
Yang and Lietman
Arch Ophthalmol 2007;125:989-991.
FULL TEXT
Trachoma Control: Is Azithromycin the Answer for Trichiasis Too?
Lin and Lietman
Arch Ophthalmol 2007;125:819-820.
FULL TEXT
Trachoma and Ocular Chlamydia trachomatis Were Not Eliminated Three Years after Two Rounds of Mass Treatment in a Trachoma Hyperendemic Village
West et al.
IOVS 2007;48:1492-1497.
ABSTRACT
| FULL TEXT
Comparison of an rRNA-based and DNA-based nucleic acid amplification test for the detection of Chlamydia trachomatis in trachoma
Yang et al.
Br. J. Ophthalmol. 2007;91:293-295.
ABSTRACT
| FULL TEXT
Targeted Treatment of Active Trachoma
Mabey et al.
JAMA 2007;297:588-588.
FULL TEXT
Targeted Treatment of Active Trachoma--Reply
Dean et al.
JAMA 2007;297:589-590.
FULL TEXT
Prevalence and risk factors for trachoma and ocular Chlamydia trachomatis infection in Niger
Abdou et al.
Br. J. Ophthalmol. 2007;91:13-17.
ABSTRACT
| FULL TEXT
Trachoma, antibiotics and randomised controlled trials.
Shapiro et al.
Br. J. Ophthalmol. 2006;90:1443-1444.
FULL TEXT
Elimination of trachoma: are we in danger of being blinded by the randomised controlled trial?
Wright et al.
Br. J. Ophthalmol. 2006;90:1339-1342.
FULL TEXT
Impact of annual targeted treatment on infectious trachoma and susceptibility to reinfection.
Atik et al.
JAMA 2006;296:1488-1497.
ABSTRACT
| FULL TEXT
Mass Antibiotic Distribution and Its Effect on Trachoma
Dinerman
AAP Grand Rounds 2006;16:31-32.
FULL TEXT
Can a Single Mass Antibiotic Treatment Eradicate Endemic Trachoma?
JWatch Infect. Diseases 2006;2006:7-7.
FULL TEXT
What's new in the other general journals.
Tonks
BMJ 2006;332:654-655.
FULL TEXT
In brief
BMJ 2006;332:566-566.
FULL TEXT
|
